menu
    • menu

    Company profile for Certa Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our novel class of drugs has the potential to be an essential therapy in the treatment of serious inflammatory and fibrotic diseases, including systemic sclerosis, chronic kidney disease, focal segmental glomerulosclerosis, diabetic retinopathy and other diseases. Our mission is to advance these novel therapeutics through clinical development to provide precision medicine treatments for these conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Certa TherapeuticsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 9, 31 Queen Street Melbourne VIC 3000
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://certatherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Certa Expands GPR68 Platform through Acquisition of OccuRx
    Certa Expands GPR68 Platform through Acquisition of OccuRx

    19 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/19/2999579/0/en/Certa-Therapeutics-Expands-GPR68-Platform-through-Acquisition-of-OccuRx.html

    GLOBENEWSWIRE
    19 Dec 2024
    Share Share
    Certa Therapeutics Names GPR68 Inhibitor Asengeprast
    Certa Therapeutics Names GPR68 Inhibitor Asengeprast

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946375/0/en/Certa-Therapeutics-Announces-International-Non-Proprietary-Name-for-its-First-in-class-GPR68-Inhibitor-Asengeprast-FT011.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    Certa's FT011 Gets EU Orphan Status For Systemic Sclerosis Treatment
    Certa's FT011 Gets EU Orphan Status For Systemic Sclerosis Treatment

    22 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/22/2916275/0/en/Certa-Therapeutics-Receives-EU-Orphan-Designation-for-FT011-a-GPR68-Inhibitor-Being-Developed-as-an-Anti-Fibrotic-Treatment-for-Systemic-Sclerosis.html

    GLOBENEWSWIRE
    22 Jul 2024
    Share Share
    Brandon Capital raises $180M for Australia, New Zealand biotechs
    Brandon Capital raises $180M for Australia, New Zealand biotechs

    04 Jun 2024

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/brandon-capital-raises-180m-fund-support-australia-new-zealand-biotechs

    Annalee Armstrong FIERCE BIOTECH
    04 Jun 2024
    Share Share
    Certa FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis
    Certa FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis

    19 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/19/2831083/0/en/Certa-Therapeutics-FT011-Granted-US-FDA-Fast-Track-for-the-Treatment-of-Systemic-Sclerosis.html

    GLOBENEWSWIRE
    19 Feb 2024
    Share Share
    Certa presents data from a Phase 2 clinical study highlighting benefit of FT011
    Certa presents data from a Phase 2 clinical study highlighting benefit of FT011

    15 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/15/2781377/0/en/Certa-Therapeutics-presents-positive-data-from-a-Phase-2-clinical-study-highlighting-the-potential-benefit-of-FT011-as-a-novel-treatment-for-scleroderma.html

    GLOBENEWSWIRE
    15 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search